Following the aforementioned in vitro experiments, we moved to in vivo substantiation of the impact of the FOXQ1/SIRT1/β-catenin axis on xenograft formation ability and radiation resistance of radiation-resistant CRC cells. This evidence concerns the gene FOXQ1 and colorectal carcinoma.